(S)-Methyl 2-((tert-butoxycarbonyl)amino)-3-(3,4-dihydroxyphenyl)propanoate, 95.0%, 100g

[(2,5-dimethoxyphenyl)methyl](propan-2-yl)amine, 95.0%, 1g

Plan PLPHi S100x/1,25 contraste de fase IOS lente corregida al infinito

1-chloro-9H-thioxanthen-9-one, 98%, 250mg

2-IODO-5-(TRIFLUOROMETHYL)PHENYLACETONITRILE, 95.0%, 250mg

tert-butyl 2-cyano-2-hydroxycyclohexylcarbamate, 50mg

2-(1,1-dimethylethyl)-4-(3-hydroxypropoxy)-6-(5-methoxy-2H-benzotriazol-2-yl)-phenol, 250mg

4-Methoxy-3-methylpyridine, 95.0%, 1g

2-(Trifluoromethyl)-5,6,7,8-tetrahydro[1,2,4]triazolo[1,5-a]pyrazine, 95.0%, 5g

Lucifer Yellow CH (dipotassium), 5mg

2-Nitro-1H-benzo[d]imidazole, 95.0%, 100mg

tert-Butyl 1-oxo-4-(pyridin-3-yl)-2,8-diazaspiro[4.5]decane-8-carboxylate, 98%, 250mg

N-(2-AMINO-2-SULFANYLIDENEETHYL)BENZAMIDE, 97.0%, 250mg